DIVIDEND ANNOUNCEMENT: Gilead Sciences Inc (NASDAQ:GILD) on 04/29/2021 declared a dividend of $0.7100 per share

Gilead Sciences Inc (NASDAQ:GILD) on 04/29/2021 declared a dividend of $ 0.7100 per share payable on June 29, 2021 to shareholders of record as of June 15, 2021.

Gilead Sciences Inc (NASDAQ:GILD) has paid dividends since 2015, has a current dividend yield of 4.4072003365% and has increased its dividends for 5 successive years.

Gilead Sciences Inc's market cap is $ 80,974,852,920 and has a PE ratio of 644.40. The stock price closed yesterday at $ 64.44 and has a 52 week low/high of $ 56.56 and $ 85.67.

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

For more information on Gilead Sciences Inc click here.